Dyne Therapeutics GAAP EPS of -$0.76 beats by $0.02
Source: SeekingAlpha
2026-03-02 07:43:24 ET
More on Dyne Therapeutics
- Dyne Therapeutics: 2026 Catalysts Point To Further Upside
- Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4
- Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity
Read the full article on Seeking Alpha
For further details see:
Dyne Therapeutics GAAP EPS of -$0.76 beats by $0.02
Dyne Therapeutics Inc.
NASDAQ: DYN
DYN Trading
-1.12% G/L:
$14.59 Last:
1,699,023 Volume:
$14.75 Open:
DYN Latest News
March 08, 2026 06:01:00 pm
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
DYN Stock Data
$2,792,339,585
138,744,373
0.04%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
